Grantham, Mayo, Van Otterloo & Co (GMO)’s Smith & Wesson SWBI Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SWBI Stock Details SWBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,010	Closed	-$215K	–	824
2020 Q2	$215K	Buy	+13,010	New	+$121K	﹤0.01%	704
2017 Q1	–	Sell	-73,651	Closed	-$1.19M	–	638
2016 Q4	$1.19M	Sell	73,651 -115,461	-61%	-$2.13M	0.01%	359
2016 Q3	$3.87M	Sell	189,112 -936,725	-83%	-$20.5M	0.02%	271
2016 Q2	$23.5M	Buy	1,125,837 +413,670	+58%	+$7.39M	0.1%	154
2016 Q1	$14.6M	Buy	712,167 +621,617	+686%	+$11.6M	0.05%	207
2015 Q4	$1.53M	Buy	+90,550	New	+$1.33M	0.01%	354

Other funds holding SWBI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SWBI Position: Q3 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Smith & Wesson (SWBI) in Q3 2020, closing a stake of 13,010 shares — an estimated $215K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SWBI in Q4 2015 and held it in 6 quarters. The position peaked at $23.5M in Q2 2016. 200 funds tracked by Wall St. Rank hold SWBI as of Q3 2020.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Smith & Wesson position as of Q3 2020 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 13,010 Smith & Wesson shares in Q3 2020, an estimated $215K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Smith & Wesson in Q4 2015 and held it in 6 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Smith & Wesson position peaked at $23.5M in Q2 2016.
200 funds tracked by Wall St. Rank held Smith & Wesson as of Q3 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2020, filed 13 Nov 2020.